A study found regular use of strong anticholinergic drugs used for bladder conditions, Parkinson's disease and depression ...

Doctors are increasingly alarmed that a type of dementia which closely resembles Alzheimer's may have resulted in the ...

Patients with diabetes undergoing hemodialysis who initiate GLP-1 agonists have an 18% lower risk for incident dementia than ...

Care for patients with dementia has changed radically since Jason Karlawish started working in the field in the late ’90s, he ...

A new international study published in Osteoporosis International and led by Monash's Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Two decades after the Women’s Health Initiative study, evolving research on menopause hormone therapy is shedding new light ...

The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...